Regular prophylaxis with exogenous factor VIII (FVIII) is recommended for individuals with severe haemophilia...
Introduction: Treatment optimization in haemophilia A can be achieved by choice of FVIII product...
The performance of surgery and invasive procedures in patients with haemophilia is currently facing new...
Hepatitis E virus (HEV) is the major cause of acute viral hepatitis in several...
Against a background of a rapidly evolving treatment landscape, a contemporary, evidence-based consolidated understanding...
The authors propose practical guidance for the diagnosis and management of COVID-19 coagulopathy in...
Abstract Background: Despite recent therapeutic advances, life expectancy in persons with congenital hemophilia A...
The work shows the problems faced by Iranian patients with congenital bleeding diseases following...
Damoctocog alfa pegol (Jivi®) is approved in the USA, EU, Japan and Canada for...
Prophylactic treatment regimens lead to improvements in health-related quality- of-life (HRQoL) among individuals with...